Keyphrases
Latently Infected
100%
AIDS/HIV
100%
Syphilis
100%
Superinfection
100%
Treponema Pallidum
38%
Human Immunodeficiency Virus Infection
30%
Fibroma
30%
Virus
23%
Human Immunodeficiency Virus Type 1 (HIV-1)
15%
Cutaneous Lesions
15%
Polymerase Chain Reaction
15%
Seroconversion
15%
Virus Sequence
15%
Immunostimulation
15%
In Situ Hybridization
7%
Initial Infection
7%
Human DNA
7%
Lymphocytes
7%
Monocytes
7%
Human Cells
7%
Mononuclear Cells
7%
Human T-cell Leukemia Virus Type 1 (HTLV-1)
7%
Causative Agents
7%
Peripheral Blood Lymphocytes
7%
Virus Type
7%
Normal Limits
7%
Delayed Hypersensitivity
7%
White Blood Cells
7%
Interleukin-2
7%
Mitogenic Response
7%
Virus Inoculation
7%
Virus-associated Cancer
7%
Skin Site
7%
White Blood Cell Count
7%
Delayed Healing
7%
Virus Expression
7%
Specific DNA Sequence
7%
Intravenous Inoculation
7%
Intradermal Injection
7%
Delayed Development
7%
Intracutaneous
7%
White Blood Count
7%
Chancre
7%
Normal White Blood Cells
7%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Leporidae
100%
Superinfection
100%
Human Immunodeficiency Virus Infection
30%
Rabbit Fibroma Virus
30%
Human Immunodeficiency Virus 1
15%
Seroconversion
15%
Leukocyte Count
15%
Immunostimulation
15%
Polymerase Chain Reaction
15%
T Cell
7%
Leukocyte
7%
Human Cell
7%
Mononuclear Cell
7%
Peripheral Blood Lymphocyte
7%
DNA Sequence
7%
Virus Type
7%
Delayed Hypersensitivity
7%
Mitogen Response
7%
Interleukin 2
7%
Back
7%
Virus Expression
7%
Treponema pallidum
7%
Lymphocyte
7%
In Situ Hybridization
7%